Form 4: Lumen Technologies Director Michelle Goldberg Receives Stock Grant
SEC Form 4 Filing
Director Michelle Goldberg received a grant of 51,394 shares of Lumen Technologies restricted stock that will vest on May 14, 2026.
Summary
- Michelle Goldberg, a director of Lumen Technologies, received a grant of 51,394 shares of common stock on May 14, 2025.
- The grant was awarded as restricted stock.
- The restricted stock will vest on May 14, 2026.
- Following the transaction, Ms. Goldberg beneficially owns 51,394 shares of Lumen Technologies stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction (stock grant) and doesn't contain any information that would significantly impact investor sentiment positively or negatively. It's a neutral event.
Positives
- The grant of restricted stock to a director aligns her interests with those of the shareholders.
Future Outlook
The document does not contain any specific forward-looking statements regarding Lumen Technologies' future performance.
Industry Context
Stock grants to directors are a common practice to incentivize and align their interests with the long-term success of the company.
Stakeholder Impact
- The stock grant aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term value.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of the stock grant transaction. |
| 05/14/2026 | Vesting date of the restricted stock. |
| 05/16/2025 | Date of signature on the Form 4 filing. |
Keywords
Lumen Technologies, Michelle Goldberg, Director, Stock Grant, Restricted Stock, Beneficial Ownership, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.